_PRIVATE_LIMITED.webp)
Glopec International (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 0.42 M
as on 25-06-2024
- Company Age 14 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 9.23%
(FY 2020)
- Profit 100.39%
(FY 2020)
- Ebitda 102.04%
(FY 2020)
- Net Worth 0.04%
(FY 2020)
- Total Assets 1.00%
(FY 2020)
About Glopec International (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.42 M, as per Ministry of Corporate Affairs (MCA) records.
Harcharan Singh, Pritam Singh, and Kashyap Shah serve as directors at the Company.
- CIN/LLPIN
U51101TG2010PTC071300
- Company No.
071300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2010
- Date of AGM
16 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Glopec International (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harcharan Singh  | Director | 22-Nov-2010 | Current |
Pritam Singh  | Director | 02-Apr-2012 | Current |
| Kashyap Shah | Director | 22-Nov-2010 | Current |
Financial Performance and Corporate Structure Insights of Glopec International (India).
Glopec International (India) Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 9.23% increase. The company also saw a substantial improvement in profitability, with a 100.39% increase in profit. The company's net worth moved up by a moderate rise of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glopec International (India)?
In 2019, Glopec International (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biophore India Pharmaceuticals Private LimitedActive 17 years 8 monthsHarcharan Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glopec International (India)?
Unlock and access historical data on people associated with Glopec International (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glopec International (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glopec International (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
